G L Knatterud
Overview
Explore the profile of G L Knatterud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baughman R, Judson M, Teirstein A, Yeager H, Rossman M, Knatterud G, et al.
QJM
. 2006 Apr;
99(5):307-15.
PMID: 16595563
Background: Some sarcoidosis patients never need therapy, but many still require therapy more than 2 years after initial diagnosis. Aim: To determine what features at initial presentation are associated with...
2.
Rabin D, Thompson B, Brown K, Judson M, Huang X, Lackland D, et al.
Eur Respir J
. 2004 Oct;
24(4):601-8.
PMID: 15459139
To determine relationships among social predictors and sarcoidosis severity at presentation, demographic characteristics, socioeconomic status, and barriers to care, A Case-Control Etiologic Study of Sarcoidosis (ACCESS) was set up. Patients...
3.
Rybicki B, Iannuzzi M, Frederick M, Thompson B, Rossman M, Bresnitz E, et al.
Am J Respir Crit Care Med
. 2001 Dec;
164(11):2085-91.
PMID: 11739139
Despite reports of familial clustering of sarcoidosis, little empirical evidence exists that disease risk in family members of sarcoidosis cases is greater than that in the general population. To address...
4.
Baughman R, Teirstein A, Judson M, Rossman M, Yeager Jr H, Bresnitz E, et al.
Am J Respir Crit Care Med
. 2001 Dec;
164(10 Pt 1):1885-9.
PMID: 11734441
Sarcoidosis may be affected by sex, race, and age. A Case Control Etiologic Study of Sarcoidosis (ACCESS) enrolled 736 patients with sarcoidosis within 6 mo of diagnosis from 10 clinical...
5.
White C, Gobel F, Campeau L, Knatterud G, Forman S, Forrester J, et al.
Circulation
. 2001 Nov;
104(22):2660-5.
PMID: 11723015
Background: The Post Coronary Artery Bypass Graft Trial, designed to compare the effects of two lipid-lowering regimens and low-dose anticoagulation versus placebo on progression of atherosclerosis in saphenous vein grafts...
6.
White C, Campeau L, Canner P, Domanski M, Forrester J, Gobel F, et al.
Am J Cardiol
. 2001 Jan;
87(1):40-3.
PMID: 11137831
Although many investigators have evaluated the technical variability of quantitative angiographic techniques used to study atherosclerosis regression in native coronary arteries, few have studied the variability inherent in repeated studies...
7.
Domanski M, Borkowf C, Campeau L, Knatterud G, White C, Hoogwerf B, et al.
J Am Coll Cardiol
. 2000 Nov;
36(6):1877-83.
PMID: 11092659
Objectives: The study was done to assess patients in the Post-Coronary Artery Bypass Graft (Post-CABG) trial to determine prognostic factors for atherosclerosis progression. Background: Saphenous vein grafts (SVGs) are effective...
8.
Knatterud G, Rosenberg Y, Campeau L, Geller N, Hunninghake D, Forman S, et al.
Circulation
. 2000 Jul;
102(2):157-65.
PMID: 10889125
Background: The Post Coronary Artery Bypass Graft Trial, designed to compare the effects of 2 lipid-lowering regimens and low-dose anticoagulation versus placebo on progression of atherosclerosis in saphenous vein grafts...
9.
10.
Pepine C, Bourassa M, Chaitman B, Davies R, Kerensky R, Sharaf B, et al.
J Card Surg
. 2000 Mar;
14(1):1-8.
PMID: 10678439
Background And Aim: The Asymptomatic Cardiac Ischemia Pilot is the first randomized trial where revascularization involved choice of either coronary bypass or angioplasty used in an early or a delayed...